Discovery and Preclinical Characterization of XMT-1660, an Optimized B7-H4-Targeted Antibody–Drug Conjugate for the Treatment of Cancer

por Toader, Dorin, Fessler, Shawn P., Collins, Scott D., Conlon, Patrick R., Bollu, Reddy, Catcott, Kalli C., Chin, Chen-Ni, Dirksen, Anouk, Du, Bingfan, Duvall, Jeremy R., Higgins, Stacy, Kozytska, Mariya V., Bellovoda, Kamela, Faircloth, Chelsey, Lee, David, Li, Fu, Qin, Liuliang, Routhier, Caitlin, Shaw, Pamela, Stevenson, Cheri A., Wang, Jason, Wongthida, Phonphimon, Ter-Ovanesyan, Elena, Ditty, Elizabeth, Bradley, Stephen P., Xu, Ling, Yin, Mao, Yurkovetskiy, Alexandr V., Mosher, Rebecca, Damelin, Marc, Lowinger, Timothy B.
Publicado 2023